한국투자금융지주 김남구 부회장의 시너지경영

이상철(Sang Cheol Lee),김주원(Joo Won Kim) 한국경영학회 2018 Korea Business Review Vol.22 No.3

한국의 금융투자기업이 변화된 환경에 적합한 사업구조를 갖추고 고객의 수요에 적합한 상품과 서비스를 제공함으로써 신뢰를 회복할 수 있는 경쟁력을 갖추는데 필요한 요건을 모색하기 위해, 본 연구에서는 한국금융투자업계의 변화를 선도하며 뛰어난 경영성과를 창출하고 있는 한국투자금융지주 김남구 부회장의 시너지경영 사례를 분석하였다. 사례를 분석하기 위해 김남구 부회장 시너지경영의 기초를 전문성과 정도경영에서 파악하고, 이러한 기초 위에 구축한 장기주의경영이라는 토대와 시너지경영의 구체적인 사례에 초점을 맞추었다. 한국투자금융지주 김남구 부회장의 시너지경영은 전문성과 정도경영에 기초를 두고 있다. 김남구 부회장은 철저한 현장경험, 학업을 통한 자기계발, 전문가들의 전문성을 활용하기 위한 노력 그리고 방대한 양의 독서와 메모하는 생활습관 등을 통해 업에 대한 전문성을 쌓아왔다. 김남구 부회장은 등기임원으로 직접 경영에 참여하여 책임경영을 실천하고 있으며, 전문경영인과의 신의, 권한위임 그리고 공정한 성과평가와 보상을 바탕으로 오너-전문경영인 파트너십을 구축하였다. 그리고 전문경영인이 주인의식을 갖고 기업가정신을 발휘할 수 있도록 지원 및 협력함으로써, 전문경영인의 전문성이 장 · 단기 성과에 직결될 수 있도록 촉진하였다. 또한 솔선수범하는 도덕적 리더십을 발휘하여 정도경영을 한국투자금융지주의 사풍으로 정착시켰다. 한국투자금융지주 김남구 부회장은 전문성과 정도경영이라는 기초위에 장기주의경영이라는 토대를 구축하였다. 김남구 부회장은 열정과 도전정신을 바탕으로 자신만의 스토리를 만들어갈 수 있는 인재를 선발하여 자신과 함께 꿈을 펼칠 파트너로 인정함으로써, 믿고 맡기는 신뢰에 기반한 조직문화를 정착시켰다. 김남구 부회장은 이러한 조직문화를 바탕으로 창출된 조직역량을 통해 고객수익률을 최우선으로 삼는 방향으로 리테일 패러다임을 변화시켰다. 또한 김남구 부회장은 장기적인 관점에서 수익성을 높일 수 있는 가치동인을 발굴하여 지속적으로 투자함으로써, 고객의 만족과 신뢰를 회복하고 주주가치를 극대화시키는 장기주의경영을 실천하고 있다. 김남구 부회장은 전문성과 정도경영의 기초위에 장기주의경영이라는 토대를 쌓고 시너지경영을 실행하고 있다. 김남구 부회장은 성공적인 인수합병을 통해 규모의 경제를 확보하고 각 계열사들의 경쟁력을 업계 최고 수준으로 끌어올림으로써, 기존 사업영역의 강점을 바탕으로 새로운 사업영역을 개척하는 전략적 시너지를 추구하고 있다. 또한 김남구 부회장은 지주회사를 중심으로 한 투명한 지배구조를 통해 다양한 사업간 시너지역량을 극대화하고 있다. Synergy management of Namgoo Kim, Vice Chairman of Korea Investment Holdings, is based on both professionalism and ethical management. First, Kim has accumulated expertise in business through rich field experience, academic studies, efforts to utilize various external specialists and life style of reading and taking notes of vast amounts of information. In addition, Kim not only establishes an owner-professional management partnership based on trust, authority delegation, fair performance evaluation and compensation with professional managers but also supports and cooperates with professional managers to demonstrate entrepreneurial spirit with a sense of ownership. Second, Vice Chairman Namgoo Kim participates in management as a board member and competes fairly in business based on his accumulated expertise through faithful management. Furthermore, by demonstrating ethical leadership, Kim set up a corporate culture of ethical management. Synergy management of Vice Chairman Kim is established on the basis of long-term management. With his passion and challenging spirit, Kim has selected talented people who can make their own stories and recognized them as partners to dream with him, thus establishing an organizational culture based on trust. Kim changed the retail paradigm to combine the organizational competence based on this organizational culture with the business process for customer-oriented management execution, and to make customer profitability a top priority from a long-term perspective. In addition, Kim is pursuing a long-term management that maximizes shareholder value by continuously investing in and discovering value drivers from a strategic and long-range point of view. Kim`s long-term management expands into synergy management. Kim is seeking strategic synergies by securing economies of scale through successful mergers and acquisitions and by raising the competitiveness of each affiliate to the highest level in the industry. Furthermore, establishing the holding company with a wholly owned subsidiary system, Kim maximizes the synergy capability among various businesses by securing the flexibility of integration and coordination.

한국인 직무 스트레스 측정도구의 개발 및 표준화

장세진,고상백,강동묵,김성아,강명근,이철갑,정진주,조정진,손미아,채창호,김정원,김정일,김형수,노상철,박재범,우종민,김수영,김정연,하미나,박정선,이경용,김형렬,공정옥,김인아,김정수,박준호,현숙정,손동국 大韓産業醫學會 2005 대한직업환경의학회지 Vol.17 No.4

Background and Purposes: Over the past three decades, numerous studies performed in Korea have reported that job stress is a determinant risk factor for chronic diseases and work disability. Every society has its own culture and occupational climate particular to their organizations, and hence experiences different occupational stress. An occupational stress measurement tool therefore needs to be developed to estimate it objectively. The purpose of this study is to develop and standardize the Korean Occupational Stress Scale (KOSS) which is considered to be unique and specific occupational stressors in Korean employees. Subjects and Methods: Data were obtained from the National Study for Development and Standardization of Occupational Stress (NSDSOS Project: 2002-2004). A total of 12,631 employees from a nationwide sample proportional to the Korean Standard Industrial Classification and the Korean Standard Occupational Classification were administered. The KOSS was developed for 2 years (2002-2004). In the first year, we collected 255 items from the most popular job stress measurement tools such as JCQ, ERI, NIOSH and OSI, and 44 items derived from the a qualitative study (depth interview). Forty-three items of KOSS, in the second year, were retained for use in the final version of the KOSS by using Delphi and factor analysis. Items were scored using conventional 1-2-3-4 Likert scores for the response categories. Results: We developed eight subscales by using factor analysis and validation process: physical environment (3 items), job demand (8 items), insufficient job control (5 items), interpersonal conflict (4 items), job insecurity (6 items), organizational system (7 items), lack of reward (6 items), and occupational climate (4 items). Together they explained 50.0% of total variance. Internal consistency alpha scores were ranged from 0.51 to 0.82. Twenty-four items of the short form of the KOSS (KOSS-SF) were also developed to estimate job stress in the work setting. Because the levels of the subscales of occupational stress were gender dependent, gender-specific standard norms for both the 43-item full version and the 24-item short form using a quartile for the subscales of KOSS were presented. Conclusion: The results of this study suggest that KOSS might be an appropriate measurement scale to estimate occupational stress of Korean employees. Further and more detailed study needs to be conducted to improve the validity of this scale.

정신분열병에 대한 리스페리돈의 효과 및 안정성

이민수,김용구,김영훈,연병길,오병훈,윤도준,윤진상,이철,정희연,강병조,김광수,김동언,김명정,김상훈,김희철,나철,노승호,민경준,박기창,박두병,백기청,백인호,손봉기,손진욱,양병환,양창국,우행원,이정호,이종범,이홍식,임기영,전태연,정영조,정영철,정인과,정인원,지익성,채정호,한상익,한선호,한진희,서광윤 大韓神經精神醫學會 1998 신경정신의학 Vol.37 No.1

연구목적 : 본 시험의 목적은 임상시험 시작전에 연구자들을 대상으로 PANSS Workshop을 통하여 PANSS, ESRS에 대한 국내에서의 표준화 작업을 구축하고 새로운 정신병 치료제인 리스페리돈의 효과와 안정성을 재확인하여 리스페리돈 사용에 대한 적정화를 이루는데 있다. 연구방법 : 1996년 4월부터 1996년 9월까지 국내 39개 대학병원 정신과에 입원중인 혹은 증상이 악화되어 입원하는 정신분열병 환자 377명을 대상으로 다시설 개방 연구를 시행하였다. 1주일간의 약물 배설기간을 가진후, 리스페리돈을 8주간 투여하였고, 기준점, 1주, 2주, 4주, 그리고 8주후에 평가되었다. 용량은 제1일에는 리스페리돈 1mg씩 1일 2회, 제2일에는 2mg씩 1일 2회, 제3∼7일에는 3mg씩 1일 2회 투여하였다. 이후 환자의 임상상태에 따라 임의로 증량할 수 있으며, 최대 일일 16mg을 초과하지 않도록 하였다. 추체외로 증상을 조절하기 위한 투약을 허용하였다. 임상증상 및 부작용의 평가는 PANSS(Positive and Negative Syndrome Scale), CGI(Clinical Global Impression) 그리고 ESRS(Extrapyramidal Symptom Rating Scale)을 사용하였다. 연구결과 : 377명중 343명(91%)이 8주간의 연구를 완결하였다. 치료 종결시점인 8주후 PANSS 총점수가 20% 이상 호전된 경우를 약물 반응군으로 정의할때, 약물반응군은 81.3%였다. 리스페리돈에 반응하는 예측인자로는 발병연령, 이전의 입원 횟수, 유병기간이 관련 있었다. 리스페리돈은 1주후부터 PANSS양성, 음성, 및 일반정신병리 점수상에 유의한 호전을 보여 효과가 빨랐다. CGI의 경우도 기준점에 비해 1주후부터 유의한 감소를 나타내었다. ESRS의 경우, 파킨슨 평가점수는 기준점과 비교해 투여 1주, 2주, 4주후 유의하게 증가되었다가 8주후 기준점과 차이가 없었다. Dystonia 평가점수는 1주후만 유의한 증가를 보였으며, dyskinesia 평가점수는 유의한 차이가 없었다. 혈압, 맥박수의 생명징후 및 일반 혈액학 검사, 생화학적 검사, 심전도 검사에서 유의한 변화는 없었다. 결 론 : 이상의 다시설 개방 임상 연구를 통해 리스페리돈은 정신분열병 환자에서 양성증상뿐만 아니라 음성증상 및 전반적인 증상에도 효과적인 것으로 사료된다. 보다 명확한 평가를 위해서는 다른 항정신병약물과의 이중맹검 연구가 필요할 것으로 생각되며, 또한 장기적 치료에 대한 평가도 함께 이루어져야 하겠다. Objective : The purpose of this study was to investigate the efficacy and safety of risperidone in the treatment of Korean schizophrenic patients. Method : This multicenter open study included 377 schizophrenic patients drawn from 39 university hospitals. After a wash-out period of 1 week, the schizophrenic patients were treated with risperidone for 8 weeks and evaluated at 5 points ; at baseline, and 1, 2, 4 and 8 weeks of treatment. The dose was increased from 2mg/day(1mg twice daily) to 6mg/day(3mg twice daily) during the first week and adjusted to a maximum of 16mg/day over the next 7 weeks according to the patient's clinical response. Medication to control extrapyramidal symptoms was permitted. The psychiatric and neurological status of the patients was assessed by PANSS, CGI, and ESRS scales. Results : 343(91%) of 377 patients completed the 8-week trial period. Clinical improvement, as defined by a 20% or more reduction in total PANSS score at end point, was shown by 81.3% of patients. The predictors of response to risperidone were associated older age, shorter duration of illness, fewer previous hospitalization. Risperidone had rapid onset of action ; a significant decrease of the total PANSS and three PANSS factor(positive, negative, general), and CGI was already noticed at the end of first week. For the ESRS, parkinsonism rating scores were significantly increased until week 4 comparing with baseline. Dystonia rating scores were significantly increased until week 1, and dyskinesia rating scores were not significantly changed during the study. Laboratory parameters including vital sign, EKG, hematological, and biochemical values showed no significant changes during the trial. Conclusions : This study suggests that risperidone is generally safe and effective against both the positive and negative symptoms in our group of patients.

만성 승모판 패쇄부전증 환자에서의 안지오텐신 전환효소 억제제의 장기 투여 효과

김대희,이명묵,이해영,조현재,박승정,서재빈,서정원,양한모,윤창환,조상호,이준희,김용진,김명아,손대원,오병희,박영배 대한순환기학회 2004 Korean Circulation Journal Vol.34 No.2

정상과 갑상선 종양조직에서 사람 IGF-I 유전자의 발현

김성운,장현하,박상미,김덕윤,우정택,양인명,김진우,김영설,김광원,고석환,홍성화,최영길 경희대학교 유전공학연구소 1993 遺傳工學論文集 Vol.5 No.-

Many of the growth-promoting properties of growth hormone(GH) are mediated by insulin-like growth factor-I(IGF-I), a highly conserved circulating 70-amino acid peptide. Recent studies have shown that multiple mechanisms influence IGF-I gene expression, including transcription from two promoters, alternative RNA splicing, and variable polyadenylation. In thyroid tissue, thyroid stimulating hormone(TSH) and IGF-I are the most possible candidates for follicular cell proliferation and hypertrophy. Actually IGF-I had autocrine and paracrine effect for tissue growing. We prepared thyroid tumor tissue mRNAs using single step method for detecting IGF-I levels according to different tissues, i.e., thyroid adenoma or papillary thyroid carcinoma. We used Northern blot analysis for IGF-I mRNA and RNase protection assay (RPA) for IGF-I transcription start sites. For Northern blot, we used whole human IGF-I cDNA as a DNA probe and for RPA, we used IGF-I exon 1 containing noncoding promoter 1 as a riboprobe. We got good RNA bands from Northern blot analysis around 1 kb (IGF-IA) and 7.5 kb (IGF-IB) region. To clarify the amount of both IGF-IA and IB mRNAs, we measured autoradiographied signal of IGF-I mRNAs bands using densitometer. In IGF-IA signals, there's no change among liver and thyroid tissues, but in case of IGF-IB mRNA bands, the signal was markedly increased in thyroid carcinoma tissues than that of normal thyroid tissue (85% vs 14%). In the study of RPA, all thyroid tissues used the same transcription start sites as those of liver's. We concluded that that this different regulation of IGF-I mRNA was originated from tissue specificity. That meant some tissue specific transcription factor/s were related to tissue IGF-I expression.

Urinary tissue inhibitor of metalloproteinase-2 and insulin-like growth factor-binding protein 7 as biomarkers of patients with established acute kidney injury

( Won Yong Cho ),( Sung Yoon Lim ),( Ji Hyun Yang ),( Se Won Oh ),( Myung-gyu Kim ),( Sang-kyung Jo ) 대한내과학회 2020 The Korean Journal of Internal Medicine Vol.35 No.3

Background/Aims: Urinary tissue inhibitor of metalloproteinase-2 (TIMP-2) and insulin-like growth factor-binding protein 7 (IGFBP7) have been recently discovered and validated as sensitive biomarkers that can predict stage 2 or 3 acute kidney injury (AKI) development in high-risk patients. We aimed to assess whether these biomarkers could predict adverse outcomes and renal recovery in established AKI patients. Methods: This was a single-center study prospectively enrolling 124 patients diagnosed with AKI. TIMP-2, IGFBP7, neutrophil gelatinase-associated lipocalin (NGAL), and kidney injury molecule 1 (KIM-1) levels were measured at the time of diagnosis and the predictive performance of short-term outcomes and renal recovery was assessed. Results: Patients were divided into 4 quartiles according to the initial urinary TIMP-2/IGFBP7 levels. Stage 3 AKI (odds ratio [OR], 17.86), classified by the Kidney Disease Improving Global Outcomes (KDIGO), as well as the third and fourth quartiles of TIMP-2/IGFBP7 (OR, 5.75 and 44.98, respectively), were found to be independent predictors of renal replacement therapy at the time of AKI diagnosis. In addition, KDIGO stage 3 AKI (OR, 2.468) or the third of fourth quartiles of urinary TIMP-2/IGFBP7 (OR, 1.896 and 3.622, respectively) were also found to be useful in predicting nonrecovery of renal function. In a separate analysis of patients with renal recovery at discharge, initial urinary TIMP-2/IGFBP7 or urinary IGFBP7 at discharge could also predict new-onset or progressive chronic kidney disease (CKD). Conclusions: In AKI patients, urine TIMP-2/IGFBP7 could serve as a biomarker for predicting adverse outcomes, renal recovery, or the development and progression of CKD.

조갑진균증의 치료에서 터비나핀과 이트라코나졸의 이중맹검 비교연구 : 공동연구

김기홍,최종수,송준영,김상원,김수찬,안성구,성열오,서순봉 대한화학요법학회 1995 대한화학요법학회지 Vol.13 No.2

저자들은 새로 개발된 alyllamine계 항진균제인 터비나핀의 발톱의 조갑백서에서 치료 효과, 내약성 및 부작용 등을 평가하기 위해 triazole계의 이트라코나졸과 이중 맹검으로 비교 조사하였다. 치료방법은 터비나핀은 250㎎/days로 12주간, 이트라코나졸은 100㎎/day로 124주간 복용하고 양군 모두 치료 시작 후 36주까지 추적 관찰하였다. 조사방법은 조갑진균증 환자에 대해 치료에 대해 설명후 동의서를 받고 장기간 치료가 부적합한 경우를 제외한 149명(터비나핀군 74명, 이트라코나졸군 75명)이 치료를 받았으며 이중 25명이 탈락하고 13명이 부작용등으로 치료를 중지하여 111명(터비나핀군 51명, 이트라코나볼군 60명)이 치료를 완료하였다. 1. 임상적인 소견은 점진적으로 호전되었으며, 치료 시작후 36주에는 병변조갑의 감소 비율로 볼때 터비나핀군은 51명중 완전치료가 24(47.0%), 76%이상 호전이 18명(35.3%), 51%~75% 호전이 6명(11.8%), 26~50% 호전이 2명 (3.9%), 25% 이하의 호전을 보인 예는 1명(2.0%)였다. 이트라코나졸군은 60명중 완전치료가 27(45.0%), 76% 이상 호전이 14명(23.3%), 51%~75%호전이 9명(15.0%), 26~50% 호전이 2명(3.9%), 25% 이하의 호전을 보인 예는 1명(2.0%)였다. 이트라코나졸군은 60명중 완전치료가 27(45.0%), 76% 이상 호전이 14명(23.3%), 51%~75%호전이 9명(15.0%), 26~50% 호전이 7명 (11.7%), 25% 이하의 호전을 보인예는 3(5%)였다. 2. KOH도말 검사에서 음성 소견을 보인 비율은 터비나핀은 24주 후 50예(98.0%)였으며, 36주후에는 모두 음성을 나타내었고, 이트라코나졸은 치료 24주 후 51예(85.0%)였고, 36주후에는 59예(98.3%)에서 음성을 나타내었다. 진균배양 검사에서는 치료 12주 후에 터비나핀군은 51예중 44예에서 (86.3%), 이트라코나졸군은 60예중 52예에서 각각 음성이었으며(86.7%), 치료 36주 후에는 양군 모두에서 음성이었다. 3. 내약성은 양군 모두 시간이 지나면서 증가하였으며, 터비나핀은 moderate이상이 98~·00%였고, 이트라코나졸은 moderate이상이 96.7~100%였다. 4. 부작용은 위장관 증상이 가장 많았고 터비나핀은 23명, 이트라코나졸은 37명이었고, 2명, 3명에서 각각 일시적인 간효소치의 상승이 있었다. 이상의 결과로 보아 조갑진균증의 치료에 터비나핀 1일 250㎎씩 12주간의 경구투여는 치료율, 안정성 및 부작용에서, 추천할 만한 치료법이라 생각된다. In this randomized double-blind trial on multicenter study, the efficacy of the new antifungal agent, terbinafine(Lamlsil) was compared with the triazole antifungal agent, itraconazole, in the treatment of patients with onychomychosis. One hundred and forty nine patients(74 terbinafine, 75 itraconazole) with onychomlychosis were enrolled. Twenty five patients were lost to follow up and 13 reported adverse reaction with premature discontinuation of therapy. And 111 patients were eligible for follow-up until 36 weeks after starting the treatment. Fifty one patients received Lamisil(terbinafine) 250mg daily for twelve weeks (terbinafine group) and 50 received itraconazole 100mg daily for 24 weeks (itraconazole group). They were checked clinical symptoms(onycholysis, subungual hyperkeratosis, paronychyal inflammation, color change, brittleness, ridging, normal length of nails) and mycological improvement with KOH wet mount and culture during the study. Clinical improvements were slow but progressive. In terbinafine group of 5t patients, 24 patients(47.0%) were completely cleared and 18 patients(35.3%) were improved more than 76%, and 6 patients(11.8%) were improved in 53-75%. In itraconazole group of 60 patients, 27 patients(45.0% ) were completely cleared and 14 patients(23-3%) were improved more than 76%, and 9 patients(150%) were improved in 51-75% . In mycologic study, cure rate of the terbinafine group showed all negative at 36 week after the treatment while ittraconazole group showed all negative in culture but negative KOH in 98.3%. Adverse reactions and tolerability of both the drugs were good and net different significantly. All these findings suggest that the efficacy of Lamisil(terbinafine) 250mg daily for 12 weeks in the treatment of onychomycosis was similar to that of itraconazole 100mg daily for 24 weeks.

Productivity Loss of Rheumatoid Arthritis Patients according to the Their Stages of the Disease Activity Score

( Sang-Cheol Bae ),( Jin-Hye Cha ),( Jung-Yoon Choe ),( Sung Jae Choi ),( Soo-Kyung Cho ),( Won-Tae Chung ),( Chung-Il Joung ),( Young-Ok Jung ),( Young Mo Kang ),( Dong-Wook Kim ),( Jinseok Kim ),( Y 대한류마티스학회 2018 대한류마티스학회지 Vol.25 No.2

Objective. Productivity loss was compared by 3-stage of disease activity and associations between higher disease activity and high productivity loss were identified. Methods. Data were extracted from Rheumatoid Arthritis (RA) Patient-reported Outcomes Research, which enrolled 2,000 RA patients (>20-year) on disease-modifying-antirheumatic-drugs (DMARDs) (≥ 6-month) from December 2012 to June 2013. This included 1,457 RA patients with the disease activity score (DAS-28-ESR) in their medical charts. Productivity loss in time and indirect cost was estimated using The World Health Organization Health and Work Performance Questionnaire (HPQ). Baseline characteristics and productivity loss outcomes were compared according to DAS-28-ESR groups. Results. 84.4% were females, 54.2% had low DAS-28-ESR (<3.2), and 38.2% and 7.6% had moderate (3.2∼5.1) and high DAS-28-ESR (>5.1). Patients with moderate to high DAS-28-ESR had higher lost productivity time (LPT) and monthly costs of LPT than those with low DAS-28-ESR (time in hours: 110.0±58.4 vs. 132.4±57.2 vs. 71.5±52.0, p<0.0001; monthly costs of LPT in 1,000 Korean won: 1,097±607 vs. 1,302±554 vs. 741±531, p<0.0001). Multiple regression analyses revealed significant associations with high LPT in high (adjusted odds ratio [OR]=3.87, 95% confidence interval [CI]: 2.18∼6.87) and moderate DAS-28-ESR (adjusted OR=1.88, 95% CI: 1.41∼2.52) compared to low DAS-28-ESR. In addition, positive associations with high monthly costs of LPT were observed in high (adjusted OR=3.45, 95% CI: 1.98∼5.99) and moderate DAS-28-ESR (adjusted OR=1.93, 95% CI: 1.43∼2.54) compared to low DAS-28-ESR. Conclusion. Timely therapeutic strategies should be taken into consideration given that the RA patients with moderate to high DAS-28-ESR showed strong associations with high productivity loss for effective management of RA. (J Rheum Dis 2018;25:122-130)

노래부르기 음악프로그램이 정신질환자의 자아존중감과 대인관계에 미치는 영향

홍상희,윤지원,이재금,김지연 병원간호사회 2006 임상간호연구 Vol.11 No.2

Purpose: The objective of this study was to verify the effects of the Singing program for psychiatric patients on their self-esteem and interpersonal relationship, and to provide data for the nursing intervention that is necessary for making their life better. Method: The subjects were 10 in-patients with psychotic disorders at C university hospital in Seoul, from july 3 to September 18 im 2005, and the methodology was one group pre experimental- post experimantal design. The instrument for the measurement of self-esteem is Rosenberg Self-Esteem Scale(1973), which was translated by Chun Byung Jae(1974) and the measurement of interpersoral relationship is Schleim & Guerney Relationship Change Scale(1971) which was translated by Mun Seok Mo(1980) and revised by Chun Seok Gyun(1994). SPSS program was used for the analysis of the collected data, which were analyzed by the paired t-test and one-way ANOVA. Result: Singing therapy had an effect on improvement of the self-esteem, and seemed to be more effective as the frequency of the program increased. Singing therapy had an effect on improvement of the interpersonal relatinship, and seemed to ne more effecive as the frequency of the program increased. Comclusion: Singing therapy is found out to be effective program affecting the improvement of both the self-esteem and interpersonal relationship of the psychiatric patients. Therefore the nurses can use the Singing therapy as the nursing intervention for imtrovement of the self-esteem and interpersonal relationship of the psychiatric patients in clinical practice.

Mycobacterium mageritense에 의한 당뇨병성 족부 감염증 1예

김충종,김낙현,김문석,김계형,전재현,박문석,박경운,박완범,박상원,김홍빈,김남중,오명돈,최강원 대한감염학회 2008 감염과 화학요법 Vol.40 No.6

Diabetic foot infection is one of the important complications in patients with advanced diabetes mellitus. Limb threatening infections such as osteomyelitis, abscess, and necrotizing fasciitis are frequently accompanied by the disease. Non-tuberculous mycobacterium (NTM) is a rare causative organism of diabetic foot infection. Thus, if one is not suspicious or meticulous, infection due to NTM will be easily overlooked and this will result in delayed diagnose and treat. Therefore, it is necessary to consider NTM as the causative organism if the wound does not respond to the conventional antibiotic treatment and the culture from the adequately obtained specimen reveals atypical acid-fast bacilli. We present a case of diabetic foot infection with osteomyelitis and abscess due to Mycobacterium mageritense, one of the rapid growing mycobacteria, that was successfully treated with surgical debridement and appropriate antibiotic treatment.